June 4 - 5, 2025
Javits Convention Center

10 States Where Cannabis Is – Or Was – Up For A Vote in 2023

Proposals for legislation heavily influence cannabis industry progress, and business leaders closely follow the actions of both state governments and Washington, D.C. to understand how the industry may be affected. Which states have taken action — or inaction — so far in 2023? 

Pennsylvania

Pennsylvania, which is one of the largest medical cannabis markets in the U.S., is experiencing renewed interest in adult-use legalization this year. Bipartisan legislation Senate Bill 846 would legalize recreational cannabis for adults and establish infrastructure, taxation, and law enforcement provisions related to the program. The bill would also expunge possession records for eligible Pennsylvanians. 

As of July 2023, the bill is under review by the Law and Justice Committee. A review of the bill is expected this year.

Ohio

In May 2023, Jamie Callender (R-Concord) and Casey Weinstein (D-Hudson) introduced the Ohio Adult Use Act, also known as Ohio HB 168. This act is meant to bring in a 10% sales tax on adult-use cannabis within the state. 

According to Ohio State University, if an adult-use cannabis market is established, it has the potential to generate general annual tax revenue expected to range from $276 million to $374 million by the fifth year of business.

West Virginia

West Virginia House Bill 2091 was proposed on the first day of the statehouse’s legislative session for 2023. Under House Bill 2091, the bill would decriminalize and legalize cannabis, allowing consumption and possession of up to 1 ounce for West Virginia adults. The legislation would also include a taxing mechanism “to bring more revenue to the state.” 

The next steps for the bill now rest upon the House of Health & Human Resources Committee, where the bill has sat for approval since its introduction in January. 

South Carolina

South Carolina H 3561, which has sat in committee since January 2023, would decriminalize possession of small amounts of cannabis and other substances. The bill would reduce penalties to civil citations. 

South Carolina state legislators also proposed two bills, the South Carolina Compassionate Care Act and the Put Patients First Act, in January. Both bills would legalize medical cannabis in the state. Multiple attempts to pass medical cannabis legislation have failed in the state, including a 2022 legislative attempt that passed the state Senate but failed in the House. 

Iowa

Iowa Senate File 73 is a bill that would expand the state’s medical cannabis program while legalizing adult-use consumption. This bill aims to reduce penalties for possessing cannabis for non-authorized medical use and to clear records for individuals convicted of nonviolent offenses. Since January 2023, the bill has been in subcommittee. Iowa currently has a medical cannabis program, but it’s quite restrictive.

Tennessee

Free All Cannabis for Tennesseans Act, known as Tennessee SB0168 and HB0085, would allow retail sales in the state. The bill was brought forth in January 2023. 

SB0168, the state Senate’s version of the bill, has been referred to the Senate Judiciary Committee. HB0085, the House version of the bill, has been assigned to the Criminal Justice Subcommittee and sponsors have been added to the legislation. 

Louisiana

A set of bills to regulate and legalize adult-use cannabis were pre-filed (filed in advance of a legislative session) in February 2023. HB-17 would allow the Department of Agriculture to issue and manage 10 cultivation licenses and 40 permits for retail dispensaries. HB-24 would decriminalize cannabis possession and distribution. The bill currently sits in committee.

Kansas

Legislators proposed House Bill 2363, a decriminalization measure, in February 2023. The bill would require that any person serving time for a nonviolent crime involving cannabis as the sole controlled substance must be discharged from their sentence for that office. The Kentucky legislature states that the Senate and the House are currently adjourned until January 2024 and therefore the bill will not have a hearing this year. 

In addition to the decriminalization measure, a second bill, the Adult Use Cannabis Regulation Act (House Bill 2367), was introduced to manage the cultivation, manufacturing, and sale of cannabis in the state. The bill was withdrawn from the Committee on Federal and State Affairs on March 28th. The Kansas Division of the Budget estimates that the revenue of cannabis sales is estimated to be $2.7 million in 2025.

Texas

House Bill 1805 was introduced with the aim of improving the Lone Star State’s medical cannabis program, the Texas Compassionate Use Program. The bill held support in the House of Representatives with an end vote of 127-19. 

A second proposal known as HB 218 was introduced to lessen penalties for cannabis possession up to two ounces of cannabis flower. The proposal would also lead to a reduced penalty for possessing concentrates up to one ounce from a felony to a misdemeanor.

Neither bill was scheduled for a Senate hearing after they made their way through the House. Lt. Gov. Dan Patrick (R), who controls the legislature agenda, is a staunch prohibitionist. 

Idaho

The Idaho Medical Cannabis Act (House Bill 370) was introduced outside of committees on March 24th by Representative John Vander Woude (R). The legislation would have permitted ingestibles, but not smoking or vaping products. Unfortunately, the bill did not advance.

Cannabis in Idaho is illegal for both medical and recreational uses, making it one of only a few states to not have any sort of cannabis access. Idaho has some of the toughest cannabis laws in America. However, public perception there is changing: 70 percent of Idaho residents support medical cannabis legalization in the state.

States that have legalized cannabis so far in 2023

Delaware

A pair of bills, House Bill 1 and House Bill 2, passed in April 2023. These two bills remove all penalties for personal use of cannabis and establish a framework for establishing a recreational cannabis market in the state.

Delaware is the 22nd state to legalize adult-use cannabis. The Delaware Cannabis Advocacy Network states that citizens will see the first legal cannabis sales between late 2024 and early 2025. 

Minnesota

With the signing of H.F. 100, Minnesota became the 23rd state in the United States to end cannabis prohibition on August 1, 2023. It is estimated to take 12 to 18 months for licenses to be issued and regulated sales to begin. Already existing medical cannabis stores will be allowed to participate in the adult-use market at a future date.

Have cannabis legalization efforts failed in any states so far in 2023?

Aside from the legislative efforts listed earlier in this article that show few or no signs of passing in this legislative session, there’s been one state, Oklahoma, where voters rejected adult-use legalization.

While medical marijuana has been embraced by the state, with around 400 medical dispensaries in Oklahoma City alone, votes turned against the ballot to move the state into allowing adult-use cannabis consumption.

Oklahoma State Question 820 came to the ballot for a vote on March 7th, 2023, where the measure failed by a 62 percent/38 percent margin. This vote was a setback for cannabis legalization supporters in Oklahoma, who anticipated that economic attitudes and growing support for cannabis would create a pathway for an adult-use program.

Stay in the know for state legislative developments

The changing landscape of cannabis illustrates the industry’s dynamic nature on the East Coast and beyond. Regulations will continue to evolve, and staying updated by relying on trustworthy and dependable sources is essential for continued success in this ever-developing industry.

CWCBExpo keeps cannabis entrepreneurs up to date with monthly news updates and an annual B2B conference in New York City that attracts thousands of people from around the U.S. Connect with CWCBExpo on LinkedIn, Instagram, Facebook, and Twitter (now X) to get the latest.

September 2023 National News Update: Unveiling Key Cannabis Bills in Congress 

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

 

 

As September 2023 comes to a close, the U.S. Congress once again jumps into the ongoing narrative of cannabis reform. From bipartisan efforts to advance banking bills to moves to federally legalize cannabis, the House of Representatives is at the forefront of these transformative discussions. Join us as we unpack the latest developments in cannabis legislation and defining moments of September. 

 

SAFER Banking Act clears committee

 

 

 

This story was edited on Sept. 27th, 2023 to include an update on the SAFER Banking Act.

In a milestone that has sent waves of excitement throughout the cannabis industry, the bipartisan Secure and Fair Enforcement Regulation (SAFER) Banking Act has made its way through committee.

 

On Sept. 27th, the Senate Banking Committee voted to approve the SAFER Banking Act, advancing this legislation to the Senate floor. While additional amendments are pending, the 14-9 vote of approval from the committee is breathing new life into a bill that has stalled for years.

 

U.S. Senators Jacky Rosen (D-NV) and Steve Daines (R-MT) introduced the SAFER Banking Act on September 20th, just ahead of a pivotal committee vote. The bill, formerly known as the SAFE Banking Act, aims to ensure that legal cannabis businesses can reliably access banking and insurance services, ultimately fostering safe communities and broadening economic opportunities.

 

Currently, federal regulations strictly control financial services for cannabis companies, resulting in a lack of access to crucial banking for many independent operators. Consequently, numerous businesses operate predominantly with cash, leaving operators, customers, and staff at increased risk of criminal activity. 

 

“This legislation will help make our communities and small businesses safer by giving legal cannabis businesses access to traditional financial institutions, including bank accounts and small business loans,” the senators said. “It also prevents federal bank regulators from ordering a bank or credit union to close an account based on reputational risk.”

 

In a separate statement, Senate Majority Leader Chuck Schumer (D-NY) said that he is committing to attaching legislation incentivizing state-level cannabis expungements and restoring gun rights for medical cannabis patients. Specifically, he said he would move to add the Harnessing Opportunities by Pursuing Expungement (HOPE) Act and Gun Rights and Marijuana (GRAM) Act to the final legislation.


House Democrats introduce bill to federally legalize cannabis

 

 

 

Representative Jerrold Nadler (D-NY) has rekindled efforts to federally legalize and regulate cannabis. On September 20th, Nadler reintroduced the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act, a comprehensive bill that not only seeks to dismantle the federal prohibition of cannabis but also includes provisions for taxing and expunging prior convictions related to the plant. The bill has 33 co-sponsors, all of whom are Democrats. 

 

This marks the third time the MORE Act has made its way to the House, with prior versions passing. However, its reintroduction under Republican control raises questions about its potential progression.

If passed, the MORE Act would deschedule cannabis, removing it from federal drug restrictions while allowing states to retain regulatory authority over its legality. However, it would not require states to legalize cannabis. It also proposes a federal tax structure for cannabis sales, starting at 5% for the first two years and rising to 8% percent by the fifth year. A portion of the tax revenue would be aimed at addressing the impact of federal prohibition, particularly on communities of color. 

 

Congressional committee approves CURE Act, removing cannabis as a barrier to federal employment

 

 

 

The House Oversight and Accountability Committee officially passed the Cannabis Users’ Restoration of Eligibility (CURE) Act on Sept. 20th with a 30-14 vote. Sponsored by Reps. Jamie Raskin (D-MD), Nancy Mace (R-SC), and Earl Blumenauer (D-OR), the bill aims to eliminate barriers to federal employment and security clearance based on past cannabis consumption. The CURE Act would also allow those previously denied a security clearance or a federal job opportunity based on cannabis use a chance to have the denial reviewed. Supporters of the bill included 30 House members, 10 of which are Republican. 

 

However, while initially designed to cover both past and current cannabis consumers, members adopted amendments from James Corner (R-KY) to refine specific provisions. The amended bill narrows the protections to apply exclusively to prior cannabis use. This means federal workers and security clearances could still face penalties for active consumption. Additionally, the amendment addresses language concerning agencies’ obligation to review denials based solely on cannabis use for security clearances or employment. 

 

“Federal hiring policies are confusing enough, and this is one area where we can work in a bipartisan way to clarify and codify what is largely an existing practice,” Chairman Corner said during the full committee meeting on Sept. 20th.

 

Join the conversation with CWCBExpo


The bills introduced this month are poised to shape the future of cannabis policy in the United States. Those eager to stay at the forefront of this evolving landscape must look no further than CWCBExpo. Our comprehensive coverage and
annual B2B conference offer accurate updates and the opportunity to connect and network with experienced industry professionals. With CWCBExpo, you’re not just staying informed but becoming part of the conversation. 

Mastercard’s Cannabis Ban Adds Complications to the Industry

Mastercard’s recent announcement that it would stop supporting the use of debit cards at cannabis dispensaries rocked retailers in the space, representing a major step back in the already dicey reality of payment processing for cannabis transactions. And Mastercard’s latest move isn’t the only financial restriction still facing the cannabis industry. In the absence of federal legalization, basic lending and banking services remain sparse and the dreaded IRS Tax Code Section 280E remains firmly in place. What do these ongoing barriers to normal business operations mean for cannabis businesses, and how can they overcome them?

Why did Mastercard suspend cannabis transactions?

Mastercard instructed financial institutions to stop allowing cannabis-related transactions to occur on its card network, citing the ongoing federal prohibition of cannabis as the reason for the industry-wide ban.

“Our rules require our customers to conduct lawful activity where they are licensed to use our brands. The federal government considers cannabis sales illegal, so these purchases are not allowed on our systems,” a Mastercard representative reportedly told Bloomberg, which first reported on the card network’s decision.

The result for many cannabis retailers is a return to cash-only transactions or automated clearinghouse (ACH) payments, each of which come with their drawbacks. Cash leaves cannabis dispensaries susceptible to robbery and can complicate accounting. ACH payments require customers to provide their bank account information, which can be a cumbersome and intimidating process in the retail environment. 

What can cannabis businesses do?

If you do not want to operate as a cash-only enterprise or rely on ACH payments for transactions, there are a few solutions you might consider. Unfortunately, none of them are perfect and each has their own set of drawbacks.

You may be able to find a local or regional bank that provides a solution to your state-legal cannabis market. These banks may offer bespoke payment solutions, unlike national banks which are more likely to bristle at the fact the federal government still considers cannabis a Schedule I illegal drug under the Controlled Substances Act. Of course, taking advantage of these offerings means first finding a local or regional bank that offers them and then switching your banking over to them, which may be an arduous process in itself. 

Some cannabis retailers may turn to cashless automated teller machines (ATMs), a long-standing method of working around the card networks’ restrictions on cannabis purchases. Cashless ATMs allow customers to “withdraw” the amount of their purchase (usually rounded up to the nearest multiple of 20) and then receive change in cash from a budtender. However effective, cashless ATMs are technically illegal and could be shut down at any moment if discovered, disrupting transactions and potentially bringing consequences to the dispensaries using them. 

There is also a slew of FinTech companies emerging in the cannabis space, purporting to offer transaction solutions to beleaguered retailers and their consumers. For example, there are apps that allow customers to pre-load funds into an account, and then their account is scanned at checkout to pay for the cannabis. These third-party services can vary in terms of quality and reliability, though, so it’s important to do your homework before partnering with a solution. Some of these solutions also charge exorbitant fees that could eat into your profit margin, so be sure to get a clear breakdown of costs and fees before signing up.

Payment processing is one of many cannabis financial and banking challenges

As if the Mastercard news wasn’t troubling enough, cannabis businesses continue to face the same old challenges they have since state-legal cannabis markets first came into existence. Cannabis businesses still have to contend with difficulty accessing banking, a dearth of financing options, challenges in processing payroll, and a punitive tax code that prevents them from taking normal business deductions. 

Banking

Banking has long been a challenge for cannabis businesses, for much the same reason as Mastercard chose to suspend cannabis-related transactions. Banks are often hesitant to work with an industry deemed federally illegal, even if the state-legal cannabis businesses are operating in a completely legitimate manner. 

Not only is there a fear of federal reprisal should the government take a harder line toward state-legal cannabis markets, but with cannabis banking comes additional regulatory requirements that can be costly for banks to administer. These include know your customer (KYC) and anti-money laundering (AML) requirements that track every cent in cannabis-related accounts. It also means submitting suspicious activity reports (SAR) to the federal government in response to large cash deposits or significant transfers. For many banks, it simply isn’t worth the headache to work with legal cannabis businesses.

Funding

Financing has long been a challenge for cannabis businesses as well. Most banks won’t offer conventional loans or credit cards to cannabis businesses, leaving them with pricey alternative lenders or private investors as the only option. The optimism-fueled investment frenzy has also waned in recent years, as private investors have increasingly pulled their money out of the cannabis industry (likely due, in part, to these very same financial challenges). Even cannabis businesses with healthy revenue are counting on reinvesting their profits to stay alive. The lucky few who have secured credit cards must accept heightened interest rates and fees.

IRS Section 280E

Perhaps the biggest financial challenge facing cannabis businesses is IRS Tax Code Section 280E, which prohibits cannabis businesses from taking any business deductions outside of the cost of goods sold (COGS). This means indirect costs, like marketing and sales expenses, cannot be deducted from a cannabis business’s tax bill. The result is razor-thin profit margins, even for businesses that are bringing in significant revenue. Companies that would be immensely profitable in any other industry are seeing that margin eviscerated by tax liabilities, and Section 280E isn’t going anywhere without an act of Congress.

Is federal cannabis reform on the way?

Year in and year out there has been some tepid hope for federal cannabis reform, yet despite modest progress the flagship bills supported by the cannabis industry have yet to materialize into law. 

Chief among these perennial bills is the Secure and Fair Enforcement (SAFE) Banking Act, which would protect financial institutions that offer services to state-legal cannabis businesses. Unfortunately, the bill appears to have stalled again, just as it has in several previous sessions of Congress. 

Recently, Sen. John Cornyn (R-TX) called Senate Majority Leader Chuck Schumer’s (D-NY) prioritization of the SAFE Banking Act “wishful thinking,” signaling that it may still not have the support it needs to make it through the U.S. Senate. The bill has repeatedly died in the chamber in past sessions after receiving overwhelming approval in the House of Representatives. As Congress heads into a recess, things aren’t looking any better for the SAFE Banking Act than they have in the past.

There are also multiple federal legalization bills that have been proffered, the passage of which would effectively make the SAFE Banking Act irrelevant. However, the difficulty in raising support for even modest financial reform in the cannabis space suggests that federal legalization, an even heavier lift, is still far off. Indeed, legalization bills in past sessions of Congress, like the Marijuana Opportunity. Reinvestment, and Expungement (MORE) Act, have repeatedly died in Senate committees as well.

The rocky road to stability for the cannabis industry

While the new developments from Mastercard just add to the challenges facing cannabis businesses, it’s nothing new to entrepreneurs in this space. The cannabis industry has grown up under stigma and unfair restrictions, and yet it remains one of the fastest growing industries in the U.S. Despite the obstacles that crop up and throw the industry unprecedented curveballs, the cannabis community remains resilient and determined to continue growing the industry.

To stay on top of the latest in the cannabis industry and grow your business, follow CWCBExpo on Instagram, LinkedIn, Facebook, or Twitter (now known as X), and sign up to attend our next trade show at the Javits Center in New York City.

Washington Monument and pool image for CWCBExpo national news update

July 2023 National News: Sports, Social Media Companies Continue Easing Regulations

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter to get the most recent edition when it’s published.

Welcome to the latest CWCBExpo national cannabis news update. There are some exciting developments this month, including big changes to NBA drug testing regulations and social media advertising rules. New research also highlights cannabis’s popularity among U.S. military veterans. Read on for more information on the latest happenings and updates nationwide. 

Meta will now allow CBD advertisements on Facebook and Instagram 

Meta, the parent company of Facebook, Instagram, and the new social network Threads, has officially updated its advertising policy to allow the promotion of non-ingestible CBD products. The change came not long after Twitter made a similar announcement in April

The social media giant announced on July 11 that advertisements can now promote CBD products containing up to 0.3 percent THC, which meets the federal definition of hemp, as long as the ads adhere to certain requirements. Meta has also updated its policy for non-ingestible hemp products like hemp fiber or seeds so that businesses no longer need written approval to promote the sale of such items in the U.S., Canada, and Mexico “provided that they comply with all applicable local laws, required or established industry codes and guidelines.” 

This development opens up new avenues for businesses in the CBD sector to reach a wider audience and market their products more effectively. To be clear, however, advertisers will continue to be prohibited from running ads that promote THC products or marketing cannabis products containing related intoxicating components.

NBA removes cannabis from banned substance list 

The National Basketball Association (NBA) and its players union have officially signed a collective seven-year bargaining agreement containing numerous cannabis provisions. The 676-page document removes cannabis from the league’s banned substances list for players and outlines rules allowing players to invest in and promote cannabis brands, with certain restrictions. 

Under the agreement, players will be allowed to hold a direct or indirect ownership interest (whether controlling or non-controlling) in an entity that produces or sells CBD products. These are defined by the federal government as cannabis containing up to 0.3 percent THC by dry weight. Players may also participate in promoting or endorsing brands, products, or services of CBD companies. However, players must first request permission from the NBA and the players’ association first, reports Marijuana Moment

This change opens up exciting opportunities for players to use their influence to raise awareness and support for CBD products, contributing to the growth and acceptance of cannabis in general. Other sports organizations, such as the MLB and the NHL, have loosened their restrictions on cannabis or removed it from their list of banned substances. 

Study finds that cannabis improves life for most veterans 

A recent study found that more than 90% of U.S. military veterans who use medical cannabis say it improves their quality of life, and many use cannabis as an alternative to over-the-counter and prescription medications. 

The study, conducted by researchers at the University of Massachusetts, the University of Utah, and cannabis research institutes, analyzed self-reported data from 510 veterans who said they consume cannabis. Here’s what they found: 

  • 67% of veterans said that they use cannabis daily
  • 30% of veterans said that they consume cannabis to reduce the use of other  medications, including antidepressants (25%) and non-steroidal anti-inflammatory (NSAIDs) pain relievers (17%)
  • 21% said that cannabis has allowed them to reduce their use of opioid-based medications

The study also drew attention to several demographic factors that influenced veterans’ desire to decrease their reliance on prescription medication. It was noted that veterans who were Black, who were female, who served in active combat, and who were living with chronic pain were more likely to report a desire to reduce the number of prescription medications they were taking.

Stay in the loop with CWCBExpo 

Staying informed about the latest updates in the national cannabis landscape is crucial to your cannabis business’s success. Following CWCBExpo’s monthly news updates and attending our yearly in-person conference provides an opportunity to stay ahead of the rapidly evolving world of cannabis. Don’t miss out on a chance to participate in the conversation! 

June 2023 Federal Cannabis News: Sports and Veteran Orgs Continue Warming Up to Cannabis

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter to get the most recent edition when it’s published.

Welcome to our June 2023 federal news update, where we bring you the most recent advancements in cannabis legislation and trends at the national level. In this edition, we delve into noteworthy progress at the intersection of cannabis and athletics, as well as updates regarding veteran access to medical cannabis. Join us as we take a look at some of the most impactful developments shaping the industry on a national scale. 

NCAA Panel Suggests Removing Cannabis From Banned Substances List
 

A panel established by the National Collegiate Athletic Association (NCAA) to reexamine the association’s policies around cannabis recently recommended removing the plant from the banned substance list for college athletes. 

The recommendation from the NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) is the latest in reforms to the NCAA’s cannabis policy since the group raised the threshold of THC for athletic drug testing last year. At that time, the NCAA also began reworking its penalties for cannabis use and determined that college athletes wouldn’t lose eligibility due to positive drug tests for cannabis. 

If the panel’s recommendation is accepted, it will mark the end of the current ban on cannabis use by student athletes, who are currently subjected to regular drug screenings, including cannabis. The CSMAS emphasized that drug testing should focus on substances that provided an unfair advantage and acknowledged that cannabis does not fall into this category. 

The panel’s recommendation is expected to be reviewed and considered by the governing bodies throughout the summer months. 

Senate Committee Approves Bill Allowing Expanding Veteran Access to Medical Cannabis

On June 22, the U.S. Senate Appropriations Committee approved a spending bill containing an amendment enabling U.S. Department of Veterans Affairs (VA) doctors to recommend medical cannabis to their patients in states where it’s legal. 

“Our legislation will increase funding for mental health and suicide prevention programs for veterans, get women veterans the medical care they need, support the expansion of the caregiver’s program, and so much more,” Sen. Patty Murray (D-WA), chair of the Senate Appropriations Committee and chair of the Military Construction, Veterans Affairs, and Related Agencies Subcommittee, said in a statement.

This change comes after multiple failed attempts to obtain funding for research into cannabis as a treatment for common health concerns many veterans experience. While no such legislation has passed, the amendment, sponsored by Sen. Jeff Merkley (D-OR), allows doctors to speak to their veteran patients about the pros and cons of medical cannabis and fill out related paperwork if required. 

House Committee Approves Research on Medical Cannabis and Psychedelics 

The House Armed Services Committee recently approved an amendment in a major defense bill to fund and research a pilot program studying the effects of medical cannabis and psychedelics for active-duty military members. The committee approved the measure, which was proposed by Reps. Nancy Mace (R-SC) and Morgan Luttrell (R-TX), on June 21 during a markup of the National Defense Authorization Act (NDAA). 

The program would be intended to assess the potential health effects of cannabis use among veterans and service members who are beneficiaries of the VA. The amendment calls for the pilot program to begin within 90 days of the enactment of the amendment. If that provision is followed, the pilot program would begin September 21, 2023. 

Eligibility for participation in the program would require a VA participant to have a diagnosis of post-traumatic stress disorder (PTSD), depression, or anxiety, or have been prescribed pain management. Treatments could include Psilocybin, Methylenedioxy-methamphetamine 12 (commonly known as MDMA), or other potentially beneficial psychedelics. 

NFL is Funding Research on CBD For Players With Concussions

The National Football League (NFL) and its player’s union have officially announced a joint commitment to funding additional research on the therapeutic potential of CBD as an alternative treatment for pain, particularly for players dealing with concussions. 

The NFL and the NFLPA have selected the American Society of Pain and Neuroscience and Emory University to conduct these studies, which will include participants from professional athletes from various sports. The research will focus on examining the effects of CBD and non-invasive vagal nerve stimulation in alleviating concussion symptoms and the impact of “mindfulness-based intervention” in sports medicine injuries.

“We are proud to lead the way on investigating how the use of CBD and other alternative measures could positively impact pain management for players. As within the broader scope of player health and safety, we want to ensure every treatment at our disposal clears the appropriate medical standard for wider use,” NFL chief medical officer Allen Sills said in a news release.

This decision comes after the NFL provided $1 million in funding for studies last year, exploring the potential benefits of CBD for pain recovery and reducing reliance on opioids. 

Stay Connected with CWCBExpo 

As policymakers, athletes, and veterans advocate for change, these developments testify to the ongoing evolution and acceptance of cannabis nationally. As the landscape continues to shift, it’s essential to stay informed and engaged. To stay connected, we encourage you to continue reading our news updates and consider attending events like CWCBExpo. These platforms provide invaluable opportunities to network and learn from industry leaders to shape the future of cannabis. 

April 2023 Federal Cannabis News: MLB Says Yes to CBD

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter to get the most recent edition when it’s published.

With the annual 4/20 holiday serving as a reminder of the industry’s momentum, there’s no shortage of cannabis news rolling out. From proposed legislation to strong public opinion polls to the groundbreaking sponsorship of a professional baseball team, this update will cover some of the most noteworthy federal cannabis news items. Let’s take a closer look at what’s been happening in the world of cannabis this month. 

Chicago Cubs become first Major League Baseball team with CBD sponsorship

The Chicago Cubs made history by becoming the first Major League Baseball (MLB) team to partner with a cannabis brand. The team officially signed a sponsorship agreement with Mynd Drinks, a Chicago-based drink maker specializing in infused beverages. Under the new deal, the Cubs will offer canned CBD beverages at Wrigley Stadium, the team’s historic home field in the heart of Chicago. The team will also display signs promoting Mynd Drinks throughout the stadium, allowing fans to learn more about the company and its products. 

“When MLB opened the CBD category for its clubs, it allowed us to explore new partnership opportunities and offerings,” Alex Seyferth, Vice President of Corporate Partnerships for the Chicago Cubs, said in a statement. “We’re proud to be the first club to partner with a CBD company, but what was more important to us was making sure that the brand was the right fit.”

This announcement comes just months after the MLB signed a deal with Charlotte’s Web, a leading producer of hemp-based CBD products – marking the first time a major professional sports league in the United States formed a partnership with a CBD company. 

Bipartisan lawmakers file bill to legalize medical cannabis for military veterans nationwide

In a series of cannabis measures introduced leading up to 4/20, a bipartisan contingent of House and Senate lawmakers are refiling bills to legalize medical marijuana for military veterans. Rep. Barbara Lee (D-CA), the co-chair of the Congressional Cannabis Caucus, and Sen. Brian Schatz (D-CA) reintroduced the Veterans Medical Marijuana Safe Harbor Act on Tuesday with 12 cosponsors. 

If passed, the bill would temporarily allow veterans to possess and use medical cannabis under federal law as recommended by doctors, representing a significant shift in how the federal government approaches cannabis. It would also allow physicians with the U.S. Department of Veterans Affairs (VA) to issue medical cannabis recommendations to veterans, an issue that has long prevented veterans from gaining access to such medicine. 

“In 41 states and territories and Washington, D.C., doctors and their patients can use medical marijuana to manage pain or treat a wide range of diseases and disorders, including post-traumatic stress disorder—unless those doctors work for the VA and their patients are veterans,” Schatz said in a press release. “Our bill will protect veteran patients in these jurisdictions, give VA doctors the option to prescribe medical marijuana to veterans, and shed light on how medical marijuana can help address the nation’s opioid epidemic.”

Earlier versions of the legislation were introduced in the last three Congresses but have yet to advance.

4/20 polls find that 64% of Americans support federal legalization

A CBS News poll published on 4/20 showed that 64% of Americans want cannabis to be legal in their state. Respondents included Democrats (73%), independents (66%), and Republicans (53%). Additionally, a slight majority of Americans consider cannabis consumption to be socially acceptable —  a shift from when CBS News asked this question two years ago. 

A separate poll from YouGov determined that 58% of respondents say cannabis should be legal in their state, including 65% of Democrats, 62% of independents, and 46% of Republicans. This poll also asked whether respondents felt that Congress should pass legislation to legalize cannabis at the federal level, and 55% said they strongly or somewhat supported the reform.

Both polls were published on 4/20, a day of increased awareness about cannabis policy issues, highlighting the continued support for cannabis legalization among the American public. The results demonstrate the normalization of cannabis consumption and Americans’ shifting perspective toward the plant. 

Federal bill to incentivize state-level cannabis expungement reintroduced

Reps. Dave Joyce (R-OH) and Alexandria Ocasio-Cortez (D-NY) have officially refiled a bipartisan bill to encourage state and local governments to expunge cannabis records. The Harnessing Opportunities by Pursuing Expungement (HOPE) Act aims to help states with expunging cannabis offenses by providing federal grants to reduce the financial and administrative burden of those efforts. 

“The vast majority of petty, non-violent cannabis law violations take place on the state and local level, precluding millions of Americans from fundamental opportunities such as housing and employment,” Congressman Joyce said in a statement. “As both a former public defender and prosecutor, I understand firsthand how these barriers can negatively impact families and economic growth in Ohio and across the nation. The HOPE Act works to remove those barriers in a bipartisan manner to pave the way for the American Dream and remedy the unjust war on cannabis.”

Stay informed with CWBCExpo 

From legislative developments to changing public attitudes, it’s clear that the cannabis industry is continuing to experience growth and transformation. As we move forward, we can expect many more exciting developments in the months and years ahead. Stay informed on the latest industry news by following the CWCBExpo blog or attending our annual B2B expo in New York, going strong in its ninth year! 

March 2023 Federal Cannabis News: Regulatory Movement As Medical Cannabis Consumption Doubles

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter to get the most recent edition when it’s published.

Welcome to the March 2023 edition of CWCBExpo federal news update. This month, we’re examining some significant regulatory developments, including the launch of President Joseph R. Biden, Jr.’s online pardon application and a new bipartisan bill aimed at regulating hemp derivatives as dietary supplements and food additives. Additionally, we’ll take a look at how much the consumption of medical cannabis has increased nationally in recent years. Read on to learn more about these updates and the evolving landscape of the U.S. cannabis industry. 

Biden administration opens pardon application 

The Biden administration has officially launched an online application process for individuals seeking pardons for cannabis possession charges. Individuals eligible for pardoning can now begin applying for a “certificate of proof” showing that their previous convictions have been pardoned. According to the online application, applicants may receive a “certificate indicating the person was pardoned on Oct. 6, 2022, for simple possession of marijuana.”

“The department is committed to carefully and expeditiously reviewing the applications and issuing certificates to those pardoned under the proclamation,” reads the statement on the Justice Department’s website. “For more information regarding eligibility and answers to frequently asked questions, please visit Presidential Proclamation on Marijuana Possession.”

To be eligible, individuals must have been charged or convicted with simple possession of cannabis by either a federal court or the D.C. Superior Court before October 6, 2022. Additionally, those seeking pardons must have been either a U.S. citizen or lawfully present in the country at the time of the offense and when Biden granted the pardon last year. Although the president’s pardon does not apply to state cannabis convictions, Biden has also encouraged state governments to take similar steps regarding simple possession charges. 

Bipartisan bill would regulate hemp-derived CBD as dietary supplements and beverage additives

A pair of bills aimed at regulating hemp derivatives such as CBD as dietary supplements and beverage additives has been reintroduced to Congress. The bills, sponsored by Reps. Morgan Griffith (R-VA) and Angie Craig (D-MN) follow the FDA’s January announcement that “a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.” 

The pair of bills would do the following: 

“The Food and Drug Administration has dragged its feet in properly regulating CBD and hemp-derived products on the market, creating confusion about its legal uses,” said Griffith in a press release. “Americans need better guidance, and that is why I have introduced these two pieces of legislation, which will create a pathway for regulation in both the food and dietary supplement spaces.”

Medical cannabis consumption has doubled in the U.S. since 2013

A new study investigating data from a federally funded survey revealed that the percentage of adults in the United States who acknowledge possession of a doctor’s authorization to consume cannabis has more than doubled between 2013 and 2020. 

According to the study, a question added to The National Survey on Drug Use and Health’s annual survey in 2013 asked whether any cannabis use within the past 12 months was recommended by a doctor. During the first year, 1.2 percent of respondents answered affirmatively. Seven years later, that figure had risen to 2.5 percent. The study’s authors reported that self-identified medical cannabis consumers were most likely to be male, uninsured, and generally residing in jurisdictions where it was legal under state law.

“This study documents a continued nationwide increase in use of cannabis for diverse medical purposes between 2013 and 2020,” the authors wrote. “Living in a state that legalized medical cannabis remained significantly associated with greater odds of medical cannabis use.”

The study also analyzed medical marijuana use by respondents who experienced specific medical conditions and found that relevant subgroups that experienced significantly greater odds of medical cannabis use included: poorer self-rated health statuses, past-year major depressive episodes, cocaine use disorder, and use of non-prescription pain relievers

Catch all the cannabis news with CWCBExpo

Staying up to date with local and national news is critical in the rapidly expanding industry. From regulatory changes to industry trends and innovations, being in the loop on the latest news and insights is crucial. Visit CWCBExpo’s blog page for more updates or our annual B2B conference in New York, where you can connect with other leading experts and innovators in the industry. Thanks for reading, and we hope to see you there! 

February 2023 Federal Cannabis News: U.S. Sales Are Booming, Twitter Changes Advertising Rules

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter to get the most recent edition when it’s published.

The legal cannabis industry may not yet be federally legal, but as more state markets come online there is certainly a feeling that the national cannabis industry is thriving. In this month’s federal news update, we’ll explore significant developments in the industry, including the growth in nationwide cannabis sales, Twitter’s new policy on cannabis advertising, and the IRS’ recent announcement regarding tax deductions for cannabis business owners. 

Twitter now allows advertisements from select cannabis companies

While not a government entity, this news impacts cannabis companies nationwide. In a major policy shift, Twitter will now allow cannabis advertisements to run on its platform. This decision is a significant change from the social media giant’s previous stance on cannabis content, which had strictly prohibited “the promotion of drugs and drug paraphernalia.” 

With the increasing acceptance and legalization of cannabis throughout the United States, Twitter said its policy revision is intended to reflect the changing landscape and will permit cannabis companies with proper licensing to advertise their brands. 

“As of today, in certain U.S. states, we have taken measures to relax our Cannabis Ads policy to create more opportunities for responsible cannabis marketing – the largest step forward by any social media platform,” noted the announcement from Twitter. “We look forward to helping more customers unlock the power of Twitter Ads to connect with the cannabis conversation and drive their business forward.” 

Companies will be required to pass through Twitter’s approval process, a must follow a list of rules and regulations that the company outlines here. Although companies remain prohibited from promoting the sale of cannabis, this policy change makes Twitter the only significant social media site to explicitly allow cannabis advertisements on its network. Competitors like Meta (Facebook and Instagram’s parent company) and TikTok, owned by ByteDance, currently hold strict bans on such content. For many social media platforms, the reasoning is due to ongoing federal prohibition and classification of cannabis as a Schedule I substance, despite cannabis being legal in some form in most states.

Report predicts $50.7B in U.S. adult-use cannabis sales by 2028

A recent report released by the Brightfield Group projected the U.S. cannabis industry would reach $50.7 billion in sales by 2028. The report, titled “U.S. Cannabis Market Forecast,” also included data on current sales and predicted more than $31.8 billion in sales to be reached by the end of 2023.

These projections highlight the legalization efforts of several states and the continued momentum and acceptance of the industry as a whole. Brightfield Group insights manager Matt Zehner told Forbes that the high amount of cannabis sales can be attributed to the expansion of cannabis into other sectors. 

“2022 was a big year for cannabis, with seven state markets beginning sales (six adult-use, one medical), four of which only commenced in the latter half of the year,” he said. “These markets are expected to have sizable growth over the course of the year, particularly those in populous states such as New Jersey and New York, both of which have had somewhat slow openings so far. New York only began sales in the last few days of 2022, so 2023 is effectively the market’s first year.”

The report also analyzed categories of cannabis products and discovered that while flower remains the top seller, with $11.6 billion in sales in 2022, vape products followed with $5.9 billion, and infused beverages came in third, generating $290 million. 

Cannabis operators may now qualify for some tax deductions

During a panel session at the 2023 American Bar Association Mid-Year Tax Meeting, IRS Office of Chief Counsel Luke Ortner announced that cannabis business owners will likely be able to file deductions on their personal taxes this year. In other words, the IRS will not automatically challenge claims made by cannabis business operators for the IRC Sec. 199A deduction

Enacted by the Tax Cuts and Jobs Act, Section 199A provides a deduction of up to 20% of pass-through income for qualified business owners. In other words, it offers many owners of sole proprietorships, partnerships, S corporations, and some trusts and estates, a deduction of income from a qualified trade or business on their personal tax return. 

Despite this development, it’s important to note that cannabis business owners are still subjected to IRS Sec. 280E, which denies deductions for the business expenses of any trade or business that traffics a controlled substance listed as Schedule 1 and 2 of the DEA’s list. 

While confusion remains regarding whether or not cannabis business owners could claim income deductions from a qualified trade or business on their tax returns, the recent change will provide some guidance and help business owners avoid uncertainty and surprises regarding filing and audits. It’s also important to note that while Ortner reported this decision, the IRS has yet to issue formal guidance on IRC Sec. 199A eligibility for cannabis operators. Business owners and operators should continue to consult with a tax professional to determine their eligibility for deductions. 

Stay informed with CWCBExpo

With increasing momentum toward federal legalization, cannabis businesses must remain informed about the latest developments in the industry nationwide. CWCBExpo provides a platform for industry professionals to stay up-to-date with the latest news and happenings and opportunities to connect with other key industry players. Stay in the loop on the latest news and happenings with our monthly news updates and more

National Cannabis News: Lawmakers and Advocates Continue to Encourage Reform in 2023 

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter to get the most recent edition when it’s published.

The new year is here and there’s no shortage of cannabis news headed into 2023. CWCBExpo is here to keep you in the loop about some of the biggest developments facing the industry. This month’s federal news update covers continued pleas for federal legalization (including from some elected officials), and an update on just how much cannabis was cultivated in 2022.

Lawmakers urge Biden to legalize cannabis federally

As the Biden administration continues its review of cannabis’ current federal scheduling, a group of bipartisan congressional lawmakers is urging the president to move for complete legalization. 

A letter written by the group of lawmakers and sent to President Joseph R. Biden Jr. expressed the effects that continued prohibition has had on the American people. Though Biden has been hesitant to back full legalization in the past, the letter outlines how his support could be critical for the future of America’s cannabis industry, reports Politico

“While we do not always agree on specific measures, we recognize across the aisle that continued federal prohibition and criminalization of marijuana does not reflect the will of the broader American electorate,” the letter says. “It is time that your administration’s agenda fully reflects this reality as well.”

Signees of the document include Sen. Elizabeth Warren (D-MA) and Congressional Cannabis Caucus co-chairs Reps. Earl Blumenauer (D-OR), Dave Joyce (R-OH), Barbara Lee (D-CA) and Brian Mast (R-FL). The letter is currently still in circulation on Capitol Hill and is expected to be published after a final decision is made on the SAFE Banking Act.

Department of Justice plans to speed up Biden’s pardon process

Just a few weeks after President Biden’s decision to clear records for thousands of federal possession convictions, The U.S. Department of Justice is looking to speed up the process. 

According to Marijuana Moment, pardon Attorney Elizabeth Oyer outlined a plan this week during a panel discussion hosted by Last Prisoner Project, where she shared the goal to provide applicants with a quick, efficient means of obtaining certificates for presidential marijuana pardons. According to her announcement, the new plan would allow people to gain pardon certificates through a 10-minute online application process. 

Oyer was not able to share precisely when the online application portal will open, though she expects it to be very soon. 

“We are hoping that we can expedite the process for applicants and for our review by using a web-based platform,” she said in an interview with Marijuana Moment. “We are working very closely with the Department of Justice’s IT department to develop and launch a web-based submission platform so that individuals can simply fill in their information online, click a button, submit the application, and it’s done.” 

Although formal forgiveness was automatic upon Biden’s signing of the proclamation on October 6th, 2022, the newly derailed plan is intended to provide official certificates to those who want physical proof of their pardoning. Additionally, Oyer noted that the online submissions would put the information into a format that makes it easier to review and process. 

U.S. cultivators produced more than 48.8 million pounds in 2022

Across both the legacy and regulated markets, U.S. cannabis cultivators produced more than 48.8 million pounds of flower in 2022 — more than enough to satisfy the entire nation’s demand, according to the 2022 U.S. Cannabis Supply Report. The report also found that, while legacy producers still outweigh licensed producers, the regulated market is projected to produce the majority of the nation’s cannabis by 2026 and that legal cannabis sales will grow to $81.6 billion by 2030.

Moreover, the overwhelming productive capacity between both the legacy and regulated markets means that, if the legacy market were to fully transition to the legal industry, the U.S. could become an exporter of surplus cannabis products. This comes at a time when other nations are legalizing cannabis or mulling an end to prohibition-era policies. If the export potential of the legal cannabis industry were realized, it could further fuel the growth of U.S. legal cannabis sales.

Start 2023 off in the know about cannabis industry trends

The legal cannabis industry has grown by leaps and bounds since the first states legalized markets, and 2023 is expected to be no different. No matter your area of expertise, staying up to date on all news, regulations and consumer trends is essential to establishing a successful operation. Resources like CWCBExpo’s monthly news updates and annual trade shows are a great way to set yourself up for success. Check back each month for updates on developments nationwide, as well as in the northeast.

December 2022 Federal Cannabis News: Congress Eyes Reforms As Americans Demand Legalization

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter to get the most recent edition when it’s published.

With 2023 around the corner, it’s essential to stay in the loop on trending topics and news affecting the cannabis industry. This month’s federal news update covers a recent public opinion poll that reveals Americans remain more supportive of legalization than ever, as well as some important reforms in the works at the federal level that could bring the U.S. one step closer to ending cannabis prohibition.

Biden signs medical cannabis research bill

In a first on the federal level, a bipartisan bill to simplify studying medical cannabis was signed by President Joseph R. Biden, Jr. on December 3rd.

The Medical Marijuana and Cannabidiol Research Expansion Act removes certain federal restrictions long regarded as barriers to continued research on medical applications for cannabis in the United States. It also establishes a new, simplified registration process for those who want to research cannabis for medical purposes. The bill passed the Senate unanimously and was overwhelmingly approved in the House.

The bill was celebrated by the research and scientific community. For decades, medical cannabis research was notoriously difficult, with red tape, delays, and other problematic restrictions making it near impossible to effectively research the plant. It’s believed that these meaningful changes can make a significant difference and help learn more about the plant and its myriad applications. The signing of this legislation is also widely seen as a signal that change to cannabis policy on the federal level may be easier than once thought. 

American support for legalization remains at all-time high 

Gallup released their latest public opinion poll on cannabis legalization on November 15th, reaffirming for the 10th year in a row that the majority of Americans support the legalization of cannabis. For the third consecutive year, an all-time high 68% of Americans reported they support the federal legalization of cannabis for medical or adult use. 

While support of federal cannabis legalization has remained steady in recent years, it has risen significantly since the start of the Gallup polls. Just 12% of Americans voted in favor of legalizing cannabis when Gallup first polled Americans on the question of legalization in 1969. Support grew over time, reaching 31% by 2000 and eventually surpassing 50% for the first time in 2013. Since 2016, at least six in 10 respondents supported cannabis legalization.

The annual Gallup poll includes those with no religious preference, self-identified liberals, Democrats, young adults, and those who seldom or never attend religious services. Among the variety of groups polled, those with no religious preference remain the highest number of supporters at 89%, followed by Liberals at 84% and Democrats at 81%. 

Federal job applicants may no longer need to report cannabis use

A November 23rd document published by the U.S. Office of Personnel Management (OPM) outlines potential changes to federal job applications and how new rules could treat cannabis consumers with much more leniency. 

Noting the current “legal landscape at the state level” regarding cannabis consumption, the document submitted to the federal registrar suggests that distinguishing between cannabis and other illegal substances may improve the pool of applicants for federal employee and contractor positions. Previously, reported cannabis consumption could bar job candidates from being hired for federal positions or from being awarded federal contracts.

“Questions regarding illegal drug use … are divided into separate areas to distinguish between use of marijuana or cannabis derivatives containing THC and use of other illegal drugs or controlled substances, in recognition of changing societal norms,” reads the document. 

Current job application forms ask prospective federal employees about cannabis use within one year, five years, or seven years, depending on the security level of the position they’re seeking. Under the proposed revisions, however, a person would only be asked about consumption that occurred within the past 90 days. The document remains open for public comment and has not yet been enacted as official OPM policy. 

Safe PLUS Banking Act inches forward in the Senate

Access to reliable banking services continues to be one of the biggest hurdles in the legal cannabis industry. The U.S. Senate has been working for months to finalize the “SAFE Plus” package in an effort to protect access to financial services and also the expungement of past convictions. 

Sponsored by Senate Majority Leader Chuck Schumer (D-NY), the SAFE Plus package serves as an updated version of the Secure and Fair Enforcement (SAFE) Banking Act. Though the text of the bill has yet to be released, we can expect it to include provisions regarding access to banking services and finance opportunities for cannabis businesses, as well as record expungement for those convicted on non-violent cannabis charges. According to Marijuana Moment, talks regarding the bill are intensifying in the Senate. 

“We are looking forward to reviewing the final language of the ‘SAFE Act Plus,’” Maritza Perez, director of the office of federal affairs at the Drug Policy Alliance (DPA), told Marijuana Moment. “We are ready to support meaningful reform in the SAFE Banking Act as well as the HOPE Act,” referring to a standalone expungements bill filed late last year by Reps. Dave Joyce (R-OH) and Alexandria Ocasio-Cortez (D-NY). 

Starting the new year right

Start the new year off right with all the necessary tools for success in the cannabis industry. To help your business succeed, CWCBExpo offers a variety of sources for businesses beyond our monthly news round-ups. Check out our website for more resources, including comprehensive guides, blog posts, and of course, our annual cannabis industry conference, scheduled for June 1 – 3, 2023 at the Javits Convention Center.

Loading...